David Arkowitz

David Arkowitz is an experienced finance and business development professional with a strong background in the biotechnology and pharmaceutical sectors. Currently serving as a Board Member at Kineta since December 2022, Arkowitz previously held significant leadership roles including CFO and Head of Business Development at Seres Therapeutics from June 2021 to March 2024. A former board member at F-star (acquired by Sino Biopharm), Yumanity Therapeutics, and Proteostasis Therapeutics, Arkowitz has also been the CFO of Flexion Therapeutics during its acquisition by Pacira Biosciences and held various leadership positions at Visterra (acquired by Otsuka Pharmaceutical Co), Mascoma LLC (acquired by Lallemand Inc), and Spring Bank Pharmaceuticals. Arkowitz possesses an MBA in Finance from Columbia Business School and a BA in Mathematics from Brandeis University.